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Abstract
Host gene products required for mediating the action of toxins are potential targets for reversing or controlling their
pathogenic impact following exposure. To identify such targets libraries of insertional gene-trap mutations generated with a
PiggyBac transposon in Blm-deficient embryonic stem cells were exposed to the plant toxin, ricin. Resistant clones were
isolated and genetically characterised and one was found to be a homozygous mutant of the mannosidase 2, alpha 1
(Man2a1) locus with a matching defect in the homologous allele. The causality of the molecular lesion was confirmed by
removal of the transposon following expression of PB-transposase. Comparative glycomic and lectin binding analysis of the
Man2a1 (2/2) ricin resistant cells revealed an increase in the levels of hybrid glycan structures and a reduction in terminal
b-galactose moieties, potential target receptors for ricin. Furthermore, naı¨ve ES cells treated with inhibitors of the N-linked
glycosylation pathway at the mannosidase 2, alpha 1 step exhibited either full or partial resistance to ricin. Therefore, we
conclusively identified mannosidase 2, alpha 1 deficiency to be associated with ricin resistance.
Citation: Wang W, Hale C, Goulding D, Haslam SM, Tissot B, et al. (2011) Mannosidase 2, alpha 1 Deficiency Is Associated with Ricin Resistance in Embryonic Stem
(ES) Cells. PLoS ONE 6(8): e22993. doi:10.1371/journal.pone.0022993
Editor: Je´roˆme Nigou, French National Centre for Scientific Research - Universite´ de Toulouse, France
Received November 3, 2010; Accepted July 11, 2011; Published August 23, 2011
Copyright:  2011 Wang et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This research was supported by the Biotechnology and Biological Sciences Research Council (BBSRC, www.bbsrc.ac.uk) grant number BBF0083091
(awarded to AD, SMH) and the Wellcome Trust (www.wellcome.ac.uk) grant numbers 077187 and 076962 (awarded to AB and GD respectively). Ricin was supplied
by the Biomedical Sciences Department, Dstl Porton Down, Salisbury, Wiltshire SP4 0JQ. The funding providers had no role in study design, data collection and
analysis, decision to publish or preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: cbh@sanger.ac.uk
. These authors contributed equally to this work.
Introduction
Toxins are poisonous substances produced by a wide range of
organisms in a variety of different forms including small molecules,
peptides, proteins and larger order complexes which bind, enter
and interfere with target cell functions by different mechanisms.
While many toxins mediate physiological affects by targeting
specific cellular components, the binding, entry and transport
through a cell to their site of action is dependent on interactions
with a variety of other cellular components. The identification and
study of host factors which interact with toxins is important for a
detailed understanding of how they disturb normal cellular
physiology and to identify host cell components as potential
targets for mitigating their effects.
Ricin is a heterodimeric lectin produced in the seeds of the
castor oil plant, Ricinus communis. It is a type-2 toxin, having two
chains, A and B. This toxin is extremely toxic and enters
mammalian cells through the interaction of the ricin B chain with
surface exposed b1–4 linked terminal galactose residues [1,2].
Once inside the cell, ricin holotoxin is taken into early endosomes
and a small fraction of the intoxicating protein then undergoes
retrograde transport to the cytosol, via the endosomes, trans-golgi
network (TGN) and endoplasmic reticulum (ER) [3–6], whilst the
majority recycles to the cell surface. Once in the ER, the
disulphide bridge between the A and B chain is reduced and the
free A chain can be transported into the cytosol where it
inactivates the 28S subunit of the ribosome. The process of
crossing the ER is thought to involve the Sec61 translocon [7] in a
fashion similar to that of misfolded proteins. Many steps in the
process of uptake and retrograde transport of ricin are unknown
and therefore of scientific interest.
Blm-deficient mouse ES cells have been developed as a platform
for conducting phenotype-driven recessive screens. These cells
have an elevated rate of loss of heterozygosity (LOH) approxi-
mately 20 fold higher compared with wild type ES cells. Following
mutagenesis, the Blm-deficient background greatly facilitates the
segregation of homozygous mutant clones, enabling genome wide
recessive screens in the diploid mammalian genome. Using this
genetic background we have successfully conducted screens for
DNA mismatch repair genes and retroviral resistance [8,9].
Here we describe a recessive screen designed to identify host cell
components required for ricin toxicity. In contrast to our previous
screens, PiggyBac transposon gene-trap vectors were used as
insertional mutagens in Blm-deficient ES cells in place of retroviral
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vectors. The piggyBac transposon gene-trap vectors provide more
comprehensive genome coverage and they have the additional
advantage of seamless reversion by PBase compared with
retroviral vectors [10].
In the screen described here, ricin resistant clones were directly
selected from libraries of insertionally mutated Blm-deficient ES
cells by exposing them to the toxin. A ricin-resistant clone with a
homozygous mutation in the mannosidase 2, alpha 1 (Man2a1) gene
was identified confirming the utility of PB system for recessive
genetic screens. Comparative glycomic analysis and glycosylation
inhibition studies revealed that Man2a1 deficiency altered the
sugar spectrum on the ES cell surface. Immunogold imaging
showed a reduction in ricin entry in Man2a1 deficient cells. Thus
the terminal b-galactose moieties are potential target receptors for
ricin.
Results
Screening ES cell transposon libraries for ricin resistant
mutants
Libraries of ES cells with gene trap mutations were screened in
an attempt to identify mutant cells with enhanced resistance to
ricin. Prior to screening, a selective (lethal) dose of ricin for ES cells
was established for the wild type parental cell line (AB2.2), the
Blm-deficient feeder-dependent line (NGG5. 3) and a Blm-
deficient mutant line adapted for growth in feeder-free conditions
(NN5). A clonal survival assay was performed by exposing the ES
cells to a range of ricin concentrations (1–30 pM) for 3 days and
counting colonies after 10 days. The lethal dose of ricin for all cell
lines was determined to be 10 pM after a 72 hour exposure
(Fig. 1A).
A series of PiggyBac (PB) transposon-based gene-trap vectors
(PBGTVs; Fig. 1B) containing an adenovirus splice acceptor
(adSA) or a mouse gene En2 splice acceptor (En2SA) and a b-geo
gene-trap cassette flanked by the 59 and 39 PB terminal DNA
repeats were used as the gene-trap vectors in this study. The
PiggyBac transposon offers the advantage of being reversible,
precise excision can be achieved by re-expressing the PB
transposase [11,12]. Previous studies [13] have reported that the
59 PB terminal repeat has promoter activity. To avoid any possible
influence of such an activity, the gene-trap cassette was placed in
the opposite orientation relative to the 59 PB terminal repeat. To
maximize the coverage of the genome, five vectors (PBGTVa, V0,
1, 2 and VK) were used in which the coding sequence of b-geo is
compatible with splicing from exons with different reading frames
[10,12,14].
Independent co-transfections of the PB vectors with PBase were
used to generate a gene-trap library in several sectors. Each sector
of the library contained approximately 2,000 independent gene
trap mutations, selected in G418. The clones constituting each
sector were pooled and expanded through at least 14 cell
doublings to facilitate the segregation of homozygous mutant
clones and then they were selected with ricin. Each library sector
generated varying numbers of resistant clones most of which were
sister clones. From five sectors, twenty one independent insertion
sites were analysed further. Initially the clones were screened to
determine if they harboured homozygous mutations by cloning of
the host-transposon junction fragments by splinkerette PCR. Two
clones, named F10-1 and F10-2 which originated from the same
pool, were examined further. In contrast to wild type Blm-deficient
ES cell, the gene-trap mutant F10 clones -1 and -2 were still viable
after exposure to 20 pM ricin, Figure 1C. The clonal relationship
between clones F10-1 and -2 was investigated by Southern blot
analysis using a b-geo probe and EcoRV to restrict the genomic
DNA to reveal clone specific transposon-host junction fragments,
Figure 1D. Both F10-1 and -2 showed a 5.6 kb fragment,
suggesting that they are sister clones. This was confirmed by
PCR analysis of the host-transposon junction fragments for both 59
and 39 PB ends, Figure 1E. Hence a single clone (referred to as
F10) was taken forwards for further analysis.
The ricin resistance gene-trap insertion maps to the
Mannosidase 2, alpha 1 (Man2a1) gene
Sequence analysis of the host-transposon junction from clone
F10 revealed that the PB transposon had inserted into intron 21 of
the Mannosidase 2, alpha 1 gene on chromosome 17, Figure 2A.
This insertion was confirmed to be homozygous by long range
PCR (LR-PCR) and triple primer PCR, Figures 2B and C. LR-
PCR from the F10 clone generated a 6.6 kb product which
included the whole PB transposon and 428 bp of flanking DNA
while the PCR product from the NGG5.3 cell line was a 428 bp
fragment amplified from the genomic locus, Figure 2B. The triple
primer PCR on F10 genomic DNA generated a 335 bp fragment
from the 39 PB-host junction or a 376 bp fragment from the 59 PB-
host junction but a wild type fragment was not amplified. The
same primer set only amplified the endogenous wild type 428 bp
fragment in NGG5.3 (Fig. 2C).
Reversion analysis
To establish causality between the insertion of the transposon
and the ricin resistant phenotype, the transposon was designed to
be revertible with PBase. The entire gene trap transposon cassette
can be removed with PBase which precisely excises the transposon
without leaving a footprint, Figure 3A.
The F10 cell line was transiently transfected with PBase and
plated at clonal density to isolate revertant clones. These clones
were isolated and sib-selected to test their sensitivity to ricin. Four
out of 96 tested clones regained ricin sensitivity (Fig. 3B). Analysis
of the PB-insertion site in the Man2a1 locus revealed that all four
resistant clones had lost the PB transposon from one copy of the
locus, restoring one allele to its original wild type sequence and
function (Fig. 3C). The ricin sensitivity of the heterozygous mutant
clones was evaluated by exposure to a range of ricin concentra-
tions. This revealed that the heterozygous clones were indistin-
guishable from wild type clones, illustrating that there was no
dosage affect in the heterozygous state (Fig. 3D).
Ricin resistance conferred by a glycosylation inhibitor
Man2a1 is a key enzyme in the Golgi involved in N-linked
glycosylation of proteins, a process which involves the sequential
cleavage of glucose and mannose residues from the post-
translationally added precursor structure, prior to the addition of
alternative sugars, Figure 4A.
Well characterized inhibitors are available for steps in the
glycosylation pathway, Figure 4A (numbered 1–8) [15]. In
principle, inhibition of this pathway at an appropriate point could
mimic aspects of the ricin resistance phenotype of the F10 mutant.
We tested several inhibitors, deoxynojirimycin, deoxymannojir-
imycin and swainsonine (#3, #6 and #7 respectively, shown in
red in Fig. 4A), which are believed to act prior to or on Man2a1 in
the pathway. Swainsonine is a reversible active-site inhibitor of
Lysosomal a-mannosidase and blocks the processing of high
mannose to complex type oligosaccharides. Its use 4 hours prior to
and during ricin exposure protected approximately 10–25% of the
exposed cells against ricin over and above inhibitor-free cells,
whilst the remaining two inhibitors deoxynojirimycin and
deoxymannojirimycin were less effective at all concentrations
Man2, a1 and Ricin Resistance in ES Cells
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(Fig. 4B 1). To ensure that all cells were fully exposed to the
inhibitors, pre-treatment was extended to 24 hours prior to ricin
intoxication and this led to full protection by Swainsonine (Fig. 4B
2). However, deoxymannojirimycin still only exhibited partial
protection (35% survival above that of ricin alone level) whilst
deoxynojirimycin continued to afford little protection. The former
is a specific glucosidase inhibitor of the trimming glucosidases I
and II, enzymes that sequentially remove the three glucose
residues from the precursor Glc3Man9-GlcNAc2 in N-linked
glycan biosynthesis whilst the latter is a specific a-mannosidase I
inhibitor that blocks conversion of high mannose to complex
oligosaccharides. If the block in processing of N-linked glycans
only was the direct causality of ricin resistance, inhibition of all
steps prior to the action of mannosidase 2, alpha 1 should have
been effective at inducing a level of ricin resistance. The fact that
only Swainsonine protected fully indicates the importance of this
step in the generation of the ricin receptor. Thus, it is possible that
Man2a1 is involved in other cellular processes such as the
retrograde transport of mis-folded proteins, in a similar manner
to mannosidase 1 alpha, potentially explaining why only Swainsonine
consistently confers ricin resistance to naı¨ve cells.
To confirm the impact of the mutation on surface sugars, flow
cytometric analysis was conducted of cells incubated with a range
of different FITC conjugated lectins. The F10 (Man2a1-deficient)
line exhibited a 2.5–3 fold higher level of binding to lectins with
specificity for mannose (Fig. 5A) than wild type controls. In
contrast, lectins with specificity for either galactose or sialic acid,
moieties added to the core sugar post mannosidase 2, alpha 1
action, were found to have reduced binding (Figs. 5B and 5C
respectively), with respect to the control, in the ricin resistant F10
line.
Immunogold imaging of ricin resistant cell line
To investigate how the alterations in surface glycosylation
patterns revealed by lectin binding might be affecting ricin
resistance, anti-ricin immunogold staining was conducted on cells
exposed to ricin. After treatment with 10 pM ricin for 1 hour,
control NN5 cells exhibited positive staining of the toxin
throughout the cell. Ricin was demonstrated to be distributed on
the plasma and nuclear membranes (Figs. 6A, B and C). The F10
ricin resistant cells exhibited no detectable staining (Figs. 6D and
E), indicating that reduced levels of surface exposed hybrid N-
glycans may be responsible for a reduced level of ricin binding and
a corresponding ricin resistance phenotype.
Glycomic analysis
The parental and F10 cells were subjected to glycomic analysis
(N- and O-glycans, glycosphingolipids) using MALDI-TOF MS,
Figure 7. Apart from the high mannose structures, the glycan
profiles of mutant and control cell types are similar (Supplemen-
tary Figures S1 and S2). However, two regions of these profiles
Figure 1. Mutagenesis and selection of ricin resistant mutants. A, establishing the selective dose of ricin. Viability as percentage of control
calculated from neutral red staining of AB2.2, NN5 and NGG5.3 cells after exposure to different ricin doses. B, PBGTVs vector structure showing the
position of the PiggyBac (PB) 39 and 59 inverted terminal repeats, the adenovirus (adSA) and the mouse gene En2 (En2SA) splice acceptor, the
polyadenylation site (pA) and the b-geo cassette. C, methylene blue staining of NGG5.3 cells or ricin-resistant mutant F10 clones -1 and -2 before and
after treatment with G418 or 20 pm ricin. D, Southern blot of NGG5.3 or F10 clones -1 and -2 genomic DNA probed with the b-geo probe, a fragment
of 5.6 Kb is visible in only F10 mutant clones -1 and -2. E, splinkerette PCR of the PB 59 junction generates a fragment of 329 bp and the PB 39
junction generates a product of 129 bp.
doi:10.1371/journal.pone.0022993.g001
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exhibit some clear differences. It has been demonstrated that
relative quantitation based on signal intensities of permethylated
glycans analyzed by MALDI-TOF MS is a reliable method,
especially when comparing signals over a small mass range within
the same spectrum [16]. In the region m/z 2400 to 2700 (Fig. 7 A,
B and C), the relative intensities of peaks such as m/z 2489, 2519
and 2693 which would have terminal b-linked galactose are all
reduced in Mannosidase 2, alpha 1-deficient F10 cells (relative %
intensities in AB2.2 cells 42/18/14, relative % intensities in NN5
cells 49/29/24 and relative % intensities in F10 cells 10/5/6).
Additional F10 peaks at m/z 2407 and 2564 are also observed,
which are not detectable in the profiles of the control cell lines.
These correspond to hybrid type N-glycan structures on which
only one mannosylated arm has been trimmed down and
extended, the other arm remaining high-mannose like. In the
second region of interest and at high m/z values (Fig. 8 D, E and
F, Supplementary Figures S1 and S2), the F10 mutant exhibits less
high molecular weight structures than the control. These data
suggest that the complex binding specificity of ricin does not
simply reflect the level of terminal galactose.
The O-glycan profiles (Supplementary table S2) exhibit very
simple patterns with major structures being mono- and disialylated
core-1. The samples do not show any major differences suggesting
that the Man2a1 mutation does not affect the O-glycosylation
biosynthetic pathways. The polar and non polar species of
glycolipids were also examined and also did not reveal any
differences between the F10 Man2a1-deficient and control cell
lines, revealing that this mutation did not affect the glycosphin-
golipid pathways either (Supplementary table S3).
Discussion
The action of ricin on susceptible cells leads to rapid cell death
induced by the inactivation of the 28S rRNA of the 60S ribosome
subunit [17]. Many reviewers have alluded to the mechanisms of
uptake of ricin but acknowledge a lack of full understanding. We
have successfully conducted a genetic screen in ES cells to identify
a gene, the mutation of which confers resistance to ricin
intoxication. The ricin-resistant clone identified in this screen
resulted from a homozygous mutation in the Mannosidase 2, alpha 1
gene, which encodes a Golgi enzyme involved in N-linked
glycosylation. The enzyme hydrolysis of the terminal a1–3 and
a1–6 linked mannose residues of the GIcNAcMan5GlcNAc2
intermediate gives rise to the oligosaccharide GIcNAcMan3Glc-
NAc2. This represents one of the committal steps in the
biosynthesis of complex N-glycans which will carry the terminal
Figure 2. Insertion site of PiggyBac (PB) transposon into the mannosidase 2, alpha 1 gene. A, illustration of the insertion site in intron 21
of the Man2a1 gene on murine chromosome 17. The precise insertion site and the exon 21-b-geo spliced product is shown. B, long range PCR on
DNA from F10 mutant clones -1 and -2 or NGG5.3 generates a fragment of 6.6 kb for the mutants or 428 bp for the parent confirming homozygous
insertion of the PB transposon. C, triple primer PCR confirms homozygosity by the generation of junction fragments corresponding to the PB 39 end
of 335 bp and the PB 59 end of 376 bp in F10 mutant clones -1 and -2 compared to the parental NGG5.3 428 bp.
doi:10.1371/journal.pone.0022993.g002
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b-linked galatose residues which are recognised by ricin. The
libraries used for this screen were generated in Blm-deficient ES
cells which facilitates the segregation of homozygous mutants from
pools of single allele mutations. This genetic background has
supported several successful screens [8,9,18]. The mutation
libraries used for this screen were generated using the PiggyBac
transposon to insert a conventional gene-trap cassette into the ES
cell genome [10]. One advantage of PiggyBac over other insertional
mutagens is the fully revertible nature of the mutations, since re-
expression of PBase seamlessly removes the PiggyBac transposon
from the genome. The ricin-resistant mutant identified here could
be reverted to a sensitive state by excision of the PB gene-trap
transposon from one of the two copies of the Man2a1 gene.
Our screen for ricin-resistant mutants from a PiggyBac gene-trap
ES cell library has provided direct access to a gene required for
ricin intoxication. To further our understanding of the mechanism
of resistance we investigated the cell surface lectin binding
properties and also conducted glycomic analyses on the mutant
clones. As a confirmation of the direct involvement of Man2a1 in
ricin resistance, we treated naı¨ve ES cells with inhibitors of N-
linked glycosylation and found that Swainsonine conferred
significant resistance to ricin exposure.
Meager and colleagues [19], have previously described ricin
resistant (RicR) clones of baby hamster kidney cells. A selection of
these proved to be resistant due to an inability to bind ricin.
Metabolic labelling revealed that these clones express only hybrid
and high mannose-type N-linked oligosaccharides rather than the
complex sugars found in the parental BHK cells [20,21]. Use of
the mannose specific lectin, Concanavalin A, indicated that mannose
residues were more abundant on those cells. Some of the RicR
cells were deduced to be deficient inMan2a1 activity but the causal
defect was never genetically confirmed [22]. These data closely
matched our observations on the ricin-resistant ES cell clone
identified in our study which exhibited greatly increased binding of
Figure 3. PBase reversion of mannosidase 2, alpha 1 mutation. A, illustration of the allele bearing the Man2a1PiggyBac insertion before and
after reversion with PBase. B, methylene blue staining of four revertant heterozygous clones, and the original ricin resistant F10 clone, either before or
after G418 or 20 pM ricin exposure. C, triple primer PCR demonstrating heterozygosity after reversion. D, viability as percentage of control calculated
from neutral red staining of AB2.2, NN5, F10 Man2a1 homozygous mutant and revertant cells after exposure to different concentrations of ricin (0 or
1–30 pM).
doi:10.1371/journal.pone.0022993.g003
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three different mannose specific lectins (Concanavalin A, Pisum
sativum agglutinin and Lens culinaris agglutinin).
Mannosidase 2, alpha 1 is known to cleave the N-linked
GIcNAcMan5GlcNAc2 intermediate to complete the mannose
trimming reactions and gives rise to the oligosaccharide, GIcNAc-
Man3GlcNAc2. The enzyme is mostly located in the medial-cisternae
of cells but its distribution can vary with cell type [23]. The results from
our glycomic analyses demonstrate that there are alterations in the
hybrid and complex N-glycans released from our ricin-resistant clones.
The high levels of residual complex glycans, still present in the F10
cells, indicates some redundancy in the complex N-glycan biosynthetic
pathway. There is evidence of a complementary enzyme, alpha
mannosidase llX [24] which also resides in the golgi and which can
perform similar trimming but not to the extent of Man2a1. Mice
deficient in both enzymes are mostly non-viable beyond the 18.5 d
embryonic stage indicating the importance of N-linked glycosylation in
embryo development [24,25].
A recent publication has described an isolate, Lec36, of the
human embryonic kidney HEK293T cell line, which has been
identified as ricin resistant following ethyl methanesulfonate
mutagenesis [26]. By nucleotide sequencing, the causal defect
was linked to separate mutations on both alleles of Man2a1, one
due to a point mutation at the active site and the second an in-
frame deletion of twelve nucleotides. However, chemical muta-
genesis can generate an array of unlinked and unmapped
mutations that can contribute to a mutant phenotype. These data
strongly support the results demonstrated in our homozygous
gene-trap mutagenesis system and confirms the usefulness of
screening mutation libraries in undifferentiated ES cells.
Immuno-gold imaging for ricin binding in the Man2a1-deficient
ES cell clones failed to identify ricin bound to these cells. This
suggests that the mechanism of resistance is related to the structure
of the N-linked glycoproteins on the cell surface, which could be
caused by loss of specific or general ricin-binding moieties on the
cell surface.
In conclusion, we emphasise the usefulness of the PiggyBac gene-
trap transposon system in Blm-deficient ES cells to generate
mutants and directly identify genes required for action of toxins.
Figure 4. N-linked glycosylation pathway analysis. A, diagram indicating steps and key inhibitors (numbered 1–8) involved in processing core
sugar structures. B1 assay demonstrating neutral red viability data after naı¨ve ES cells were treated with glycosylation inhibitors deoxynojirmycin (#3
in fig. 4A), deoxymannojirimycin (#6 in fig. 4A) or Swainsonine (#7 in fig. 4A) at 1, 10 or 100 mM 4 hours prior to, and during, exposure to 10 pM ricin
for 3 days. B2, a comparison of neutral red viability data after naı¨ve ES cells were treated with glycosylation inhibitors either 24 hours or 4 hours prior
to, and during, ricin exposure.
doi:10.1371/journal.pone.0022993.g004
Man2, a1 and Ricin Resistance in ES Cells
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Materials and Methods
Cell culture
AB2.2, NN5 and NGG5.3 ES cell lines. These ES cell lines
have been described previously [8]. The NN5 and NGG5.3 ES
cell lines are Blm-deficient. The AB2.2 and NN5 cells were
maintained on gelatin coated plastic in Glasgow’s minimal
essential medium (GMEM) supplemented with 10% foetal
bovine serum, 2 mM L-glutamine, 1 mM sodium pyruvate, non-
essential amino acids, 1024 M b-mercaptoethanol and 500–1000
units of leukocyte inhibitory factor (LIF)/ml. NGG5.3 ES cells
were maintained as described previously [27]. Briefly, ES cells
were maintained on gamma-irradiated SNL76/7 feeder cell layers
in Dulbecco’s modified Eagle’s medium supplemented with 15%
foetal bovine serum, 2 mM L-glutamine, 50 units/ml penicillin,
40 mg/ml streptomycin, and 1024 M b-mercaptoethanol. Cells
were cultured at 37uC with 5% carbon dioxide.
Ricin resistant F10 cells. Clones arising from exposure to
ricin were grown on SNL76/7 feeder cells until large enough to
pick into 96 well plates also bearing feeder layers. The clones were
expanded through 24 and 6 well plates until sufficient numbers
were obtained to freeze down and prepare DNA for PCR analysis.
Adaptation of F10 to feeder-free conditions. To allow
comparative experiments to be performed, feeder dependent F10
cells were trypsinised and washed once in NN5/AB2.2 medium
prior to plating into gelatinized 90 mm dishes at a 1 in 8 dilution.
Subsequent sub-culturing was performed every two days at the
same dilutions until all feeder cells were depleted.
Gene-trap vectors construction
The PiggyBac (PB) transposon vector containing 313 bp of the 59
inverted terminal DNA repeat (TR) and 235 bp of 39 inverted TR
was provided by Dr. Xiaozhong Wang (North Western Univer-
sity). The PB59 and PB39 inverted repeats were PCR amplified
and cloned upstream and downstream from the adSA- or En2SA-
b-geo gene-trap cassette and named PBGTVs.
Generation of gene-trap mutations
A single-cell clone of NGG5.3 ES cells was isolated and
expanded to minimize background mutations. Five million cells
were co-electroporated with 1 mg of gene-trap vector and 20 mg of
a PBase expression plasmid pCAGGS-PBase, in which the native
version of PiggyBac transposase coding sequence is under the
control of the CAG promoter. After electroporation the cells were
plated onto 90-mm feeder plates and G418 selection (180 mg/L
active ingredient) was initiated 24 h later and continued for 8 days
until individual ES cell clones were visible. The G418 resistant
clones within each plate were pooled and expanded for 4 days
before initiating ricin selection.
Figure 5. Mannose, galactose and sialic acid specific lectin binding analysis. Histograms of differences in Mean Fluorescence Intensity of
lectin binding to either AB2.2, NN5 or ricin resistant F10 cells. A, Mannose specific lectins ConA, PSA and LCA represent Concanavalin A, Pisum sativum
agglutinin and Lens culinaris agglutinin respectively. B, Galactose specific lectins PNA, GSL1 and ECL represent Peanut agglutinin, Griffonia (Bandeiraea)
simplicifolia lectin 1 and Erythrina cristagalli lectin respectively. C, Sialic acid specific lectins MAL1, EBL (SNA) and MAL11represent Maackia amurensis
lectin 1, Sambucus nigra lectin and Maackia amurensis lectin 11 respectively.
doi:10.1371/journal.pone.0022993.g005
Man2, a1 and Ricin Resistance in ES Cells
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Isolation of ricin resistant clones
Libraries of NGG5.3 cells with gene-trap mutations (106 cells
per 90 mm plate of feeder cells) were exposed to 20 pM ricin for 3
days; the plate was rinsed and maintained with normal medium
over the next 7 days. Resistant colonies were grown until they were
visible and picked into 96 well feeder plates.
Neutral red and methylene blue assay for determining
cell viability
NN5, AB2.2, NGG5.3 and F10 ricin resistant cells were plated
at 105 cells per well in 24 well plates and exposed to a range of
ricin concentrations for 48 h. The cells were then mixed with
0.3% neutral red, incubated for a further 1 h and washed gently
with phosphate buffered saline (PBS) for 1 h. After removal of the
PBS, remaining viable cells were solubilised in a 1% glacial acetic
acid/49% H20/50% ethanol solubilisation buffer and values
determined at OD 490 nm. As an alternative method, viable cells
were directly stained in the plates with 2% methylene blue in 70%
ethanol for 10 minutes and then washed extensively in tap water.
Isolation of the transposon–chromosome junction
Isolation of the transposon–chromosome junction was per-
formed using the splinkerette-PCR method as described [28].
The protocol was modified for use with ES cells on 96- or 24-well
plates. Briefly, genomic DNA was isolated from ES cell colonies
on 96- or 24-well plates; 2–4 mg DNA was digested with Sau3AI
and ligated with the corresponding splinkerette adaptors HMSp–
Sau3AI (generated by annealing splinkerette oligos HMSpBb–
Sau3AI with HMSpAa). A first round of PCR was carried out
with splinkerette primer HMSp1 and PB transposon primers
PB59-1 or PB39-1. Then 1% of the PCR product was directly
used for a second-round nested PCR, which was carried out with
splinkerette primer HMSp2 and the PB transposon primers PB59-
2 or PB39-2. Primers for splinkerette-PCR and sequencing are
shown in Supplementary table S1. The nested PCR products
were purified by High Pure 96 UF cleanup plate (Roche) and
were used for sequencing with primer PB59-seq or PB39-seq
separately.
Southern blotting and hybridization
Total genomic DNA was restricted; size fractionated on agarose
gels, blotted, and hybridized using standard procedures. The
following probes were used: LacZ probe, a 800 base pair ClaI
digested fragment from pSAgeo [14], which is a plasmid
containing the SA-b-geo cassette in pBlueScript.
Figure 6. Anti-ricin immunogold staining of either NN5 or ricin resistant F10 cells. A–C, images showing ricin particles located in various
sites within NN5 cells treated with 20 pM ricin for 1 h at 37uC. D and E ricin-resistant F10 cells exposed to 20 pM ricin and processed for anti-ricin
staining at the same time. NM, PM, Endo, OM and IM represent nuclear membrane, plasma membrane, endosome, outer membrane and inner
membrane respectively (small arrows). The nucleus, cytoplasm and Golgi are also indicated.
doi:10.1371/journal.pone.0022993.g006
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Figure 7. MALDI-TOF MS profiling of AB2.2, NN5 and F10 N-glycans (mz 2400–2700). The expanded region (m/z between 2400 and 2700)
is shown on the panels A, (AB2.2), B, (NN5) and C, (F10). N-glycans were permethylated prior being subjected to MS analysis and m/z values
correspond to [M+Na]+ ions. Scheme assignments are based on the precise fit between composition calculations and the m/z (z= 1) ratio of the
molecular ions detected. These schemes represent the most likely structures taking into account the biosynthetic pathways and the enzyme
repertoire of murine cells and selected MS/MS analyses. Sugar symbols are those employed by the Consortium for Functional Glycomics. Circles
represent hexoses (yellow: galactose, green: mannose), blue squares represent N-acetylglucosamine, red triangle: fucose, purple diamonds represent
N-acetylneuraminic acid.
doi:10.1371/journal.pone.0022993.g007
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Genomic long range and triple primer PCR
Genomic long range PCR (LR-PCR) was performed with
primer pairs representing the genomic sequences flanking the
PB gene-trap insertion (supplementary table S1). Using the
recommended PCR conditions (Thermo), the PCR product of
homozygous ES cell clones incorporates the 6.6 kb PB gene-trap
cassette whilst heterozygous clones only have a small 428 bp
genomic region.
Figure 8. MALDI-TOF MS profiling of AB2.2, NN5 and F10 N-glycans (mz 3650–5000). The expanded region (m/z 3650–5000) is shown on
the panels D, (AB2.2), E, (NN5) and F, (F10). N-glycans were permethylated prior being subjected to MS analysis and m/z values correspond to [M+Na]+
ions. Scheme assignments are based on the precise fit between composition calculations and the m/z (z=1) ratio of the molecular ions detected.
These schemes represent the most likely structures taking into account the biosynthetic pathways and the enzyme repertoire of murine cells and
selected MS/MS analyses. Sugar symbols are those employed by the Consortium for Functional Glycomics. Circles represent hexoses (yellow:
galactose, green: mannose), blue squares represent N-acetylglucosamine, red triangle: fucose, purple diamonds represent N-acetylneuraminic acid.
doi:10.1371/journal.pone.0022993.g008
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Triple primer PCR was performed with primer pairs repre-
senting the genomic sequences flanking the PB gene trap insertion
and one PB end primer (Supplementary table S1). The PCR
reaction was competitive between the amplifications from the
genomic sequences and the PB primer and genomic primer. The
wild type, heterozygous or homozygous ES cell clone have
different but comparable size PCR products.
PBase reversal
Five million cells were electroporated with 20 mg PiggyBac
transposase (PBase) expression plasmid, plated on 90 mm feeder
plates, and 2 days later the cells were re-plated at low density
(1,000 cells/10 cm plate) to allow the growth of individual ES cell
colonies. Clones were picked into 96-well plates and the deletion of
the PB transposon was confirmed by PCR. Ricin resistance was
assessed by plating105 cells/well in 24-well plates, exposing to ricin
for 3 days and 6 days further culture with normal medium. Cells
were visualized by staining with 2% methylene blue as described
previously.
Lectin screen
Kits of fluorescein isothiocyanate (FITC) conjugated lectins,
encompassing several sugar specificities, were purchased from
Vector Laboratories. Cells were harvested by trypsinisation and
re-suspended at 16106/ml in staining buffer (16Dulbecco’s (D)-
PBS containing 5% foetal calf serum and 0.01% sodium azide).
Aliquots of 100 ml were incubated with 2 ml (1–2 mg/ml) lectin for
20 m at 4uC prior to extensive washing with D-PBS. After fixation
in 100 ml 1% paraformaldehyde in D-PBS, stained cells were
analysed by flow cytometry on the FL-1 green channel of a Becton
Dickinson FACsAria.
Glycosylation inhibitors
The inhibitors deoxynojirimycin, deoxymannojirimycin and
swainsonine (VWR) were diluted to 100 mM in sterile D-PBS as
stock solutions. Further dilutions of 1, 10 and 100 mM [15] were
prepared in either normal media, for pre-treatment, or in medium
containing 10 pM ricin. AB2.2 or NN5 cells, plated at 0.56105/
well in 24 well plates one day earlier, were pre-treated, in
duplicates, with inhibitor for initially 4 h at 37uC prior to ricin
exposure. The inhibitor was then removed and replaced with fresh
medium containing either inhibitor and/or 10 pM ricin or ricin
alone. The cells were exposed for 3 days before neutral red
staining. Due to the nature of ES cell growth in that domed
colonies form and not monolayers, pre-treatment was extended to
24 hours in subsequent experiments to ensure full exposure to the
inhibitors.
Glycomics analysis
Pellets of 26106 cells were washed once in PBS prior to freezing
at 280uC. Corresponding aliquots of the relevant mediums were
also frozen at the same time. Glycoproteins and glycosphigolipids
(GSLs) were extracted and separated by homogenisation and
solvent partition ([29]. Cells were homogenised in 4 volumes of
ice-cold water, the total aqueous volume was determined and
glycolipids were extracted from the homogenate, by addition of
2.67 volumes of methanol and 1.33 volumes of chloroform, and
vortexed thoroughly before centrifugation at 3000 rpm for
10 min. The glycoproteins were pelleted, reduced and carbox-
ymethylated. After dialysis and lyophilisation, samples were
digested with trypsin (Bovine TPCK treated T-1246, Sigma,
Poole, UK) as previously described [30] and glycopeptides/
peptides were purified on SepPak cartridge C18 (Waters Corp,
Elstree, UK) [30]. The glycopeptides/peptides were dissolved in
200 ml of Ambic buffer (50 mM, pH 8.4). 3 U of PNGase F
(1365177, Roche Applied Science, Burgess Hill, UK) was added
and the reaction was incubated at 37uC for 24 hr, adding a fresh
3 U aliquot of enzyme after 12 hr. The digested samples were
lyophilised and redissolved in 200 ml of 5% (v/v) acetic acid before
being loaded onto a preconditioned Classic C18 Sep-PakH and
eluted with 5 ml of 5% (v/v) acetic acid (the N-glycan fraction)
followed by elution with 4 ml of 20% and 40% (v/v) propan-1-ol
in 5% (v/v) acetic acid (peptide/O-linked glycopeptide fractions).
The 5% (v/v) acetic acid and combined 20% and 40% (v/v)
propanol fractions were lyophilised. Permethylation and sample
clean-up were performed using the sodium hydroxide protocol, as
described previously [30]. Combined 20% and 40% (v/v)
propanol fractions (peptide/O-linked glycopeptide fractions)
resulting from the post-PNGase F digest were dissolved in 800 ml
of 1 M potassium borohydride (KBH4) in a 0.1 M solution of
potassium hydroxide (KOH) and incubated at 45uC for 20–22 hr.
The reaction was terminated by drop wise addition of glacial
acetic acid (5 drops). Cationic salts, amino acids and peptides were
removed from the sample using a Dowex (50W-X8 (H+) 50–
100 mesh) column. The O-glycans fractions obtained were then
permethylated using the same method as the one used for the N-
glycans.
After extraction of the pellet of glycoproteins, the supernatant
containing the GSLs was transferred to a fresh tube and water
(0.173 volumes of supernatant) added. After mixing and
centrifugation (15506 g, 10 min), two phases were obtained.
The lower phase was extracted twice with water and dried under
nitrogen. The upper phase was cleaned-up on a C18 Plus Sep-Pak
cartridge (Waters, Elstree, UK) as described earlier [29]. GSLs
were incubated with ceramide glycanase (rEGCase II, 4460,
Takara, Shiga, Japan). The reaction mixture was extracted with 1-
butanol and the aqueous phase cleaned-up on a C18 Sep-Pak
column. The glycans in the unbound fraction were purified on
Hypercarb Cartridges (Waters, Elstree, UK) and freeze-dried.
Glycans were deuteroreduced by 10 mg/mL sodium borodeuter-
ide in 2 M ammonia solution (2 h, 25uC). After neutralization with
acetic acid, the borates were removed by co-evaporation with 10%
(v/v) acetic acid in methanol. Permethylation of glycans was
performed using the sodium hydroxide procedure [31].
MALDI-TOF MS and MALDI-TOF/TOF MS/MS data were
acquired using a 4800 MALDI TOF/TOF (Applied Biosystems)
mass spectrometer. The MS spectra were obtained using the
reflector positive mode with delayed extraction. MS/MS data
were acquired using collision energy of 1 kV, and argon was used
as collision gas. Samples were dissolved in 10 ml of methanol and
mixed at a 1:1 ratio (v/v) with 2,5-dihydrobenzoic acid as matrix.
Immunogold staining of ricin and transmission electron
microscopy
Cells incubated with 20 pM ricin for 1 h were fixed with 2%
paraformaldehyde/0.2% glutaraldehyde in PBS, at 37uC for
10 minutes and then transferred to ice. The cells were rinsed three
times with PBS and briefly quenched with 0.1% glycine in PBS at
37uC, covered with 1 ml of 1% gelatin, scraped with a freshly cut
Teflon strip into a 1.5 ml Eppendorf and centrifuged at
3,000 rpm. The resulting pellet was gently re-suspended in 10%
gelatin and centrifuged again before chilling at 4uC. Small
chopped pieces were infiltrated with 2.3 M sucrose on a roller at
4uC overnight and then mounted on aluminium stubs and plunge
frozen in liquid nitrogen. 60 nm ultrathin cryosections were cut on
a Leica EM FC6 ultra microtome and labelled with rabbit anti-
ricin toxin A chain (Abcam) followed by 10 nm protein A gold
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(University of Utrecht) following the protocol of Tokayasu [32,33].
Sections were imaged on an FEI 120 kV Spirit Biotwin equipped
with a F415 CCD camera.
Supporting Information
Figure S1 MALDI-TOF MS profiling of AB2.2, NN5 and
F10 N-glycans. N-glycans were permethylated prior being
subjected to MS analysis and m/z values correspond to
[M+Na]+ ions. For clarity reason, not all the peaks are labelled
on these spectra but the m/z value and the annotations of all
detected peaks are shown in Supplementary Figure 2. Grey boxes
highlight the two regions detailed in Figures 7 and 8.
(TIF)
Figure S2 Assignments of the molecular ions observed
in the N-glycan profiles of AB2.2, NN5 and F10 cells.
Scheme assignments are based on the precise fit between
composition calculations and the m/z (z = 1) ratio of the molecular
ions detected. Ions with m/z in bold red are specific to F10 cells
only. Schemes represent the most likely structures taking into
account the biosynthetic pathways and the enzyme repertoire of
murine cells and selected MS/MS analyses.
(TIF)
Table S1 Splinkerette, sequencing and PCR primers.
Details of all splinkerette, sequencing and PCR primers utilised to
generate vectors and confirm gene trap mutations.
(DOC)
Table S2 Assignments of molecular ions [M+Na]+
observed in the MALDI-TOF MS spectra of reduced
and permethylated O-glycan derived from AB2-2, NN5
and F10 cells. NeuAc: N-Acetylneuraminic acid, Hex:
Hexose, HexNAc: N-Acetylhexosamine.
(DOC)
Table S3 Assignments of molecular ions [M+Na]+
observed in the MALDI-TOF MS spectra of deuteror-
educed and permethylated glycosphingolipids derived
from AB2-2, NN5 and F10 cells.
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 Figure S1. 
MALDI-TOF MS profiling of AB2.2, NN5 and F10 N-glycans. N-glycans were 
permethylated prior being subjected to MS analysis and m/z values correspond to 
[M+Na]+ ions. For clarity reason, not all the peaks are labelled on these spectra but 
the m/z value and the annotations of all detected peaks are shown in Supplementary 
Figure 2. Grey boxes highlight the two regions detailed in Figures 7 and 8. 
https://doi.org/10.1371/journal.pone.0022993.s001 
 
 Figure S2. 
Assignments of the molecular ions observed in the N-glycan profiles of AB2.2, 
NN5 and F10 cells. Scheme assignments are based on the precise fit between 
FRPSRVLWLRQFDOFXODWLRQVDQGWKHP]](? (?UDWLRRIWKHPROHFXODULRQVGHWHFWHG,RQV
with m/z in bold red are specific to F10 cells only. Schemes represent the most likely 
structures taking into account the biosynthetic pathways and the enzyme repertoire 
of murine cells and selected MS/MS analyses. 
https://doi.org/10.1371/journal.pone.0022993.s002 
 
Supplementary Table 1 
Splinkerette, sequencing and PCR primers.   
Details of all splinkerette, sequencing and PCR primers utilised to generate vectors and 
confirm gene trap mutations.  
 
 
Splinkerette-PCR  
HMSpAa ¶--CGAAGAGTAACCGTTGCTAGGAGAGACCGTGGCTGAAT 
GAGACTGGT GTCGACACTAGTGG--¶ 
HMSpBb-Sau3A1 ¶--GATCCCACTAGTGTCGACACCAGTCTCTAATTTTTTTTTT 
CAAAAAA--¶ 
HMSp1 ¶--CGAAGAGTAACCGTTGCTAGGAGAGACC--¶ 
HMSp2 ¶--GTGGCTGAATGAGACTGGTGTCGA--¶ 
3%¶-1 ¶--TAAATAAACCTCGATATACAGACCGATAAA--¶ 
3%¶-2 ¶--ATATACAGACCGATAAAACACATGCGTCAA--¶ 
3%¶-seq ¶--TTTTACGCATGATTATCTTTAACGTACGTC--¶ 
3%¶-1 ¶--CAAAATCAGTGACACTTACCGCATTGACAA--¶ 
3%¶-2 ¶--CTTACCGCATTGACAAGCACGCCTCACGGG--¶ 
3%¶-seq ¶--TTAGAAAGAGAGAGCAATATTTCAAGAATG--¶ 
 
Genomic Primers 
 
Man2a1-exon21-up ¶--ATGGGCAAAGGCTATTCGGATGAGGCAGCC--¶ 
Man2a1-exon22-down  ¶--GAAGCTAAAGTAATGTGCTTAGTTATTGCA--¶ 
Supplementary Table 2 
 
Assignments of molecular ions [M+Na]+ observed in the MALDI-TOF MS spectra of 
reduced and permethylated O-glycan derived from AB2-2, NN5 and F10 cells. NeuAc: 
N-Acetylneuraminic acid, Hex: Hexose, HexNAc: N-Acetylhexosamine 
 
m/z of [M+Na]+ ion Composition 
895.5 NeuAc1Hex1HexNAc1 
983.6 Hex2HexNAc2 
1187.7 Hex3HexNAc2 
1256.7 NeuAc2Hex1HexNAc1 
1344.8 NeuAc1Hex2HexNAc2 
 
 
 
Supplementary Table 3 
 
Assignments of molecular ions [M+Na]+ observed in the MALDI-TOF MS spectra of 
deuteroreduced and permethylated glycosphingolipids derived from AB2-2, NN5 and 
F10 cells. 
 
m/z of [M+Na]+ ion Composition 
855.5 NeuAc1Hex2 
943.5 Hex3HexNAc1 
1100.6 NeuAc1Hex2HexNAc1 
1147.6 Hex4HexNAc1 
1216.1 NeuAc2Hex2 
1304.7 NeuAc1Hex3HexNAc1 
1665.8 NeuAc2Hex3HexNAc1 
2027.1 NeuAc2Hex3HexNAc1 
 
 
 
